A Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of TA-46 in Healthy Volunteers

Trial Profile

A Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of TA-46 in Healthy Volunteers

Recruiting
Phase of Trial: Phase I

Latest Information Update: 21 Jun 2018

At a glance

  • Drugs TA-46 (Primary)
  • Indications Achondroplasia
  • Focus Adverse reactions
  • Most Recent Events

    • 21 Jun 2018 According to a Therachon media release, company to enable clinical trial applications in early 2019.
    • 16 Feb 2018 New trial record
    • 14 Feb 2018 According to a Therachon media release, the first subject from this trial has been dosed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top